Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study

BACKGROUND/AIMS: We aimed to evaluate the efficacy and safety of peginterferon plus ribavirin for chronic hepatitis C (CHC) patients under real life setting in Korea. METHODS: We retrospectively analyzed the medical records of 758 CHC patients treated with peginterferon plus ribavirin between 2000 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sang Hoon, Park, Choong Kee, Lee, Jin Woo, Kim, Young Seok, Jeong, Sook-Hyang, Kim, Yun Soo, Kim, Ju Hyun, Hwang, Seong Gyu, Rim, Kyu Sung, Yim, Hyung Joon, Cheong, Jae Youn, Cho, Sung Won, Lee, June Sung, Park, Young Min, Jang, Jeong Won, Lee, Chun Kyon, Shon, Joo Hyun, Yang, Jin Mo, Ju, Young Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Pancreatobiliary Association 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286746/
https://www.ncbi.nlm.nih.gov/pubmed/22375178
http://dx.doi.org/10.5009/gnl.2012.6.1.98

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286746/
https://www.ncbi.nlm.nih.gov/pubmed/22375178
http://dx.doi.org/10.5009/gnl.2012.6.1.98

Ejemplares similares